Biotechnology plays an increasingly vital role in advancing treatments for bipolar disorder, a complex mood disorder characterized by alternating episodes of mania and depression. Traditional therapies like lithium and anticonvulsants remain standard, but biotech innovations—such as induced pluripotent stem cells (iPSCs), brain organoids, genetically engineered models, and precision medicine based on genomic insights—offer promising avenues for personalized and more effective interventions. These approaches aim to model disease mechanisms at the cellular level, identify novel drug targets, and reduce side effects by tailoring treatments to genetic profiles.

Contact us